Oncology revenue surged to $14,379 million in 26H1, but biosimilar competition dragged Immunology revenue down to $7,224 million.
Johnson & Johnson is a global healthcare company that sells innovative medicines and medical technologies to patients and healthcare providers worldwide. Over the last twelve months, the company generated $97,929…